Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Nuclear Medicine

Free Subscription 09.02.2026 3 AJNR Am J Neuroradiol 6 Ann Nucl Med 1 Appl Radiat Isot 30 Clin Nucl Med 2 IEEE Trans Med Imaging 4 J Nucl Cardiol 7 J Nucl Med 2 Neurology 4 Nucl Med Commun 1 Nuklearmedizin 1 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. LUCK S, Sathi N, Shaqra H, Mozayan A, et al
   [Ga68]DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.
   AJNR Am J Neuroradiol. 2026 Jan 30:ajnr.A9183. doi: 10.3174/ajnr.A9183.
   PubMed         Abstract available
   
   
2. ALIZADA S, Al Qudah H, Debnam JM, Msherghi A, et al
   Multimodal Imaging and Clinicopathologic Features of Parathyroid Lipoadenoma.
   AJNR Am J Neuroradiol. 2026;47:430-436.
   PubMed         Abstract available
   
   
3. DE RUBEIS G, Stasolla A, Piccioli C, Federici M, et al
   The Impact of a Neuroradiologist on the Report of a Real-World CT Perfusion Imaging Map Derived from Artificial Intelligence/Machine Learning-Driven Software.
   AJNR Am J Neuroradiol. 2026;47:336-341.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

4. SHAN HM, Chen T, Fan W
   Predictive value of metabolic parameters from PET/CT in adult multifocal Langerhans cell histiocytosis.
   Ann Nucl Med. 2026 Jan 31. doi: 10.1007/s12149-026-02154.
   PubMed        
   
   
5. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
   Off-target binding of (18)F-MK-6240 tau PET imaging demonstrated by high spatial resolution dedicated brain PET scanner.
   Ann Nucl Med. 2026 Feb 2. doi: 10.1007/s12149-026-02161.
   PubMed        
   
   
6. VIJAYASIMHA M, Srikanth M
   Perfusion-only SPECT/CT for pulmonary thromboembolism: from promising criteria to globally reproducible practice.
   Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02160.
   PubMed        
   
   
7. AKSU A, Us A, Guc ZG, Kucuker KA, et al
   Pseudotime-Based derivation of a PET-Based metabolic progression index for prognostic stratification in Extensive-Stage SCLC.
   Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02162.
   PubMed        
   
   
8. IWAO Y, Akamatsu G, Sakata M, Wagatsuma K, et al
   Registration accuracy of amyloid/tau-PET to brain MRI using modified SPM method.
   Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02159.
   PubMed        
   
   
9. HOSOKAWA T, Uchiyama M, Namba S, Tanami Y, et al
   Detection rate of lymphoscintigraphy with technetium-99 m for pediatric chylopericardium.
   Ann Nucl Med. 2026 Feb 5. doi: 10.1007/s12149-026-02164.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

10. DANG P, Feng Z, Yang X, Cao X, et al
    Evaluation of exposure characteristics and radiological risks for cyclotron-based (18)F radiopharmaceutical production workers in China.
    Appl Radiat Isot. 2026;230:112474.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

11. CUI Y, Wang Y, Du B, Li Y, et al
    A Rare Linitis Plastica Manifestation of Esophageal Squamous Cell Carcinoma With Diffuse Gastric Metastasis Revealed by 18F-FDG PET/CT.
    Clin Nucl Med. 2026;51:235-236.
    PubMed         Abstract available
    
    
12. CHEN SH, Cheng NM, Fan KS, Chang PH, et al
    Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence.
    Clin Nucl Med. 2026;51:195-202.
    PubMed         Abstract available
    
    
13. MOURATO FA, Schmitt LG, Mariussi M, Torri G, et al
    The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
    Clin Nucl Med. 2026 Jan 23. doi: 10.1097/RLU.0000000000006309.
    PubMed         Abstract available
    
    
14. LEE JW, Lee SM, Kang B, Kim JS, et al
    Prognostic Value of FDG PET/CT Parameters in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine, Cisplatin, and Nab-Paclitaxel.
    Clin Nucl Med. 2026 Jan 21. doi: 10.1097/RLU.0000000000006306.
    PubMed         Abstract available
    
    
15. KUMAR SA, Goyal H, Ahmed AS, Srinivasan P, et al
    Bridging Diagnostic Gaps in AL Cardiac Amyloidosis: The Emerging Role of 68Ga-FAPI PET/CT.
    Clin Nucl Med. 2026 Jan 21. doi: 10.1097/RLU.0000000000006325.
    PubMed         Abstract available
    
    
16. XU Q, Chen Y, Song J, Guo W, et al
    Head-to-Head Comparison of [18F]MFBG and [68Ga]Ga-DOTA-TATE PET/CT in Suspected Recurrent/Refractory Neuroblastoma: Prospective Single-center Analysis.
    Clin Nucl Med. 2026 Jan 20. doi: 10.1097/RLU.0000000000006308.
    PubMed         Abstract available
    
    
17. DENIZMEN ZORBA D, Arslan DF, Sanli Y, Kuyumcu S, et al
    Optimizing Intrahepatic Cholangiocarcinoma Staging: Comparison of [18F]FDG, [68Ga]Ga-FAPI, and [68Ga]Ga-Trivehexin PET/CT Imaging.
    Clin Nucl Med. 2026 Jan 20. doi: 10.1097/RLU.0000000000006310.
    PubMed         Abstract available
    
    
18. ZHENG J, Lancaster L, Allen B
    Hepatobiliary Excretion of 99mTc-MAG3 on Renal Scintigraphy: A Diagnostic Pitfall in the Evaluation of Urine Leak.
    Clin Nucl Med. 2026 Jan 6. doi: 10.1097/RLU.0000000000006301.
    PubMed         Abstract available
    
    
19. KIM Y, Nam JH, Pak K, Choi JH, et al
    Selective Cardiac Tc-99m DPD Retention With Markedly Reduced Extracardiac Uptake in Hereditary Transthyretin Amyloidosis.
    Clin Nucl Med. 2026;51:256-258.
    PubMed         Abstract available
    
    
20. BUCKENMAYER A, Werner R, Groener D, Klimek K, et al
    Tubular MAG3 Extraction Rate is a Predictor of Short-Term and Long-Term Outcome After Kidney Transplantation: A Prospective Observational Study.
    Clin Nucl Med. 2026;51:203-210.
    PubMed         Abstract available
    
    
21. LOPEZ-BERMEJO GARCIA F, Jimenez Lara A, Rodriguez Gomez JC, Gaton Ramirez J, et al
    18 F PSMA Uptake in a Hypogastric Desmoid Tumor.
    Clin Nucl Med. 2026;51:e169-e171.
    PubMed         Abstract available
    
    
22. YANG Y, Jin Y, Zhao S, Liu L, et al
    Intense FDG Uptake in Penile Condyloma Acuminatum Mimicking Malignancy in a Melanoma Patient.
    Clin Nucl Med. 2026;51:254-255.
    PubMed         Abstract available
    
    
23. MAN X, Dong C, Dong A, Song X, et al
    High-grade 18 F-PSMA-1007 Uptake of Benign Prostatic Hyperplasia With Chronic Inflammation.
    Clin Nucl Med. 2026;51:273-275.
    PubMed         Abstract available
    
    
24. RAEISI N, Saber Tanha A, Aryana K, Shahid Sales S, et al
    99m Tc-FAPI-46 Scintigraphy and Radioligand Therapy With 177 Lu-FAPI-2286 in Locally Advanced Epithelioid Sarcoma.
    Clin Nucl Med. 2026;51:e166-e168.
    PubMed         Abstract available
    
    
25. AKSAKAL M, Liu Y, Chen DL, King G, et al
    Gallbladder Neuroendocrine Tumor and 177Lu DOTATATE: High Somatostatin Receptor Expression Without Clinical Response.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006001.
    PubMed         Abstract available
    
    
26. ISIK EG, Topal E, Barburoglu M, Kuyumcu S, et al
    68GA-DOTA-TATE PET/CT in the Assessment of Cranial and Spinal Hypertrophic Pachymeningitis.
    Clin Nucl Med. 2026 Feb 2. doi: 10.1097/RLU.0000000000006347.
    PubMed         Abstract available
    
    
27. GUNGOR S
    Incremental Diagnostic Value of 68Ga-FAPI PET/CT in Evaluating Pediatric Neuroblastoma.
    Clin Nucl Med. 2026 Feb 2. doi: 10.1097/RLU.0000000000006356.
    PubMed         Abstract available
    
    
28. TRIUMBARI EKA, Lorusso M, Cirillo F, D'Orso F, et al
    18F-FDG PET/CT Five Days Post First Administration of Semaglutide: Side Effects in One Shot.
    Clin Nucl Med. 2026 Feb 3. doi: 10.1097/RLU.0000000000006360.
    PubMed         Abstract available
    
    
29. MOHITE A, Luthra K, Pathan S, Malik A, et al
    68Ga Trivehexin PET/CT in a Breast Carcinoma Patient With Distant Metastasis: Edge Over 18F-FDG PET/CT?
    Clin Nucl Med. 2026 Jan 30. doi: 10.1097/RLU.0000000000006178.
    PubMed         Abstract available
    
    
30. RAEISI N, Saber Tanha A, Aryana K, Soltani E, et al
    Superior Diagnostic Performance of 99mTc-FAPI-46 SPECT/CT Versus 18FDG PET/CT in Detecting Peritoneal Involvement in Mucinous Adenocarcinoma of the Colon.
    Clin Nucl Med. 2026 Feb 2. doi: 10.1097/RLU.0000000000006129.
    PubMed         Abstract available
    
    
31. FOUFA Y, Maliha PG, Morin MA
    Multisystemic Malakoplakia Revealed by 18F-FDG PET/CT: A Case of Concomitant Bilateral Osteomyelitis and Genitourinary Involvement.
    Clin Nucl Med. 2026 Jan 26. doi: 10.1097/RLU.0000000000006340.
    PubMed         Abstract available
    
    
32. WANG W, Li S, Lv C, Xie P, et al
    Isolated Multiple Skeletal Muscle Metastases Detected By 123I-MIBG SPECT/CT in a Patient WithIntermediate-Risk Neuroblastoma.
    Clin Nucl Med. 2026 Jan 29. doi: 10.1097/RLU.0000000000006335.
    PubMed         Abstract available
    
    
33. QUINTERO K, Esforzado N, Ventura Aguiar P, Perissinotti A, et al
    18F-FDG_PET/CT Uptake in Pancreatic Transplant.
    Clin Nucl Med. 2026 Jan 30. doi: 10.1097/RLU.0000000000006334.
    PubMed         Abstract available
    
    
34. AKERELE M, Singh B, Mikell J, Kaur K, et al
    Clinical Dosimetry Models and Pathway to Integration in Routine Nuclear Medicine Practice.
    Clin Nucl Med. 2026;51:e203-e218.
    PubMed         Abstract available
    
    
35. ZHANG A, Zu M, Ma Y, Ding S, et al
    18FAl-NOTA-FAPI PET/CT Outperforms 18F-FDG PET/CT in Detecting Gastrointestinal Metastasis of Lobular Breast Carcinoma.
    Clin Nucl Med. 2026;51:e181-e182.
    PubMed         Abstract available
    
    
36. ZHANG J, Dong A, Wang Y
    FDG PET/CT in a Case of Primary Tracheal ALK-Negative Anaplastic Large Cell Lymphoma.
    Clin Nucl Med. 2026;51:283-284.
    PubMed         Abstract available
    
    
37. MATSUSAKA Y, Suzuki K, Seto A, Kato Y, et al
    Failure of 18F-florbetapir Amyloid PET Imaging after Injection With an Automated Injector Using an Air-vent Filter for FDG Injection.
    Clin Nucl Med. 2026;51:271-272.
    PubMed         Abstract available
    
    
38. LIU X, Zhao Y, Tian C, Wang W, et al
    A case of sarcomatoid carcinoma of the lung treated with a new radiopharmaceutical 225Ac-DOTA-IBA.
    Clin Nucl Med. 2026;51:268-270.
    PubMed         Abstract available
    
    
39. ABDLKADIR AS, Haddad H, Mohamad I, Al-Ibraheem A, et al
    [68Ga]Ga-FAPI Surpasses [18F]FDG in Pancreatic Adenosquamous Carcinoma Restaging.
    Clin Nucl Med. 2026;51:250-251.
    PubMed         Abstract available
    
    
40. WANG J, Jin X, Shi X, Jing H, et al
    18F-FDG PET/CT Findings in a Case of Primary Leptomeningeal Melanomatosis With Diastematomyelia.
    Clin Nucl Med. 2026;51:237-239.
    PubMed         Abstract available
    
    

    
    IEEE Trans Med Imaging

41. HASHIMOTO F, Gong K
    PET Image Reconstruction Using Deep Diffusion Image Prior.
    IEEE Trans Med Imaging. 2026;PP.
    PubMed         Abstract available
    
    
42. HAN K, Hu D, Zhao F, Liu T, et al
    Incomplete Multi-Modal Disentanglement Learning With Application to Alzheimer's Disease Diagnosis.
    IEEE Trans Med Imaging. 2026;45:632-645.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

43. KOUNGA C, Ciuffo L, Shiyovich A, Divakaran S, et al
    Significant Vasodilator-Induced Hypotension: A Mimic of Vasodilator Non-Responsiveness in PET/CT Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2026 Jan 29:102639. doi: 10.1016/j.nuclcard.2026.102639.
    PubMed        
    
    
44. ALWAN M, El Yaman A, Al Rifai M, Escobar S, et al
    Optimizing Protocol Efficiency in [(18)F]Flurpiridaz PET MPI Through Dose Ratio-Driven Reduction of Relative Residual Activity.
    J Nucl Cardiol. 2026 Jan 30:102644. doi: 10.1016/j.nuclcard.2026.102644.
    PubMed         Abstract available
    
    
45. IQBAL I, Liljenback H, Andriana P, Stahle M, et al
    Folate receptor ss-targeted PET imaging of activated macrophages in experimental myocardial infarction.
    J Nucl Cardiol. 2026 Feb 2:102653. doi: 10.1016/j.nuclcard.2026.102653.
    PubMed         Abstract available
    
    
46. SARASTE A, Knuuti J
    New opportunities for nuclear cardiology with total-body PET/CT.
    J Nucl Cardiol. 2026 Feb 2:102652. doi: 10.1016/j.nuclcard.2026.102652.
    PubMed         Abstract available
    
    

    
    J Nucl Med

47. SCHRAUWEN C, Halloin N, Van Eetveldt A, Laermans Z, et al
    SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord Injury.
    J Nucl Med. 2026 Feb 5:jnumed.125.271236. doi: 10.2967/jnumed.125.271236.
    PubMed         Abstract available
    
    
48. MACCIONI L, Knyzeliene A, Alcaide-Corral CJ, Reid VJM, et al
    Network-Based Analysis for the Quantification of Brain and Body Immune Axes with Total-Body PET Imaging.
    J Nucl Med. 2026 Feb 5:jnumed.125.271514. doi: 10.2967/jnumed.125.271514.
    PubMed         Abstract available
    
    
49. LI Z, Providencia L, Mohr P, Mostafapour S, et al
    Validation of a Deep-Learning Coregistration Framework for Long-Axial-Field-of-View PET/CT Using Low-Radiation-Exposure Protocols Across Various Tracers.
    J Nucl Med. 2026 Feb 5:jnumed.125.270420. doi: 10.2967/jnumed.125.270420.
    PubMed         Abstract available
    
    
50. HOENIG MC, Dzialas V, Doering E, Bischof GN, et al
    Modifiable Factors Associated with the Longitudinal Increase and Spatial Extent of Tau Pathology in Alzheimer Disease.
    J Nucl Med. 2026;67:291-296.
    PubMed         Abstract available
    
    
51. ROHRICH M, Glatting FM, Geisinger M, Spektor AM, et al
    Digital Biopsy and Network Analysis of Dynamic [(68)Ga]Ga-FAPI-46 Data in Patients with Malignant and Benign Pancreatic Lesions.
    J Nucl Med. 2026;67:304-312.
    PubMed         Abstract available
    
    
52. MORTENSEN ACL, Mohajershojai T, Gustafsson A, Berglund H, et al
    Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials.
    J Nucl Med. 2026;67:269-275.
    PubMed         Abstract available
    
    
53. FRAGOSO-NEGRIN JA, Vergara-Gil A, Rahman Hakim A, Hardiansyah D, et al
    OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry.
    J Nucl Med. 2026;67:276-282.
    PubMed         Abstract available
    
    

    
    Neurology

54. VRILLON A, Spina S, Mejia-Perez J, Lamore T, et al
    Association of [(18)F]Flortaucipir-PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders.
    Neurology. 2026;106:e214576.
    PubMed         Abstract available
    
    
55. HALL BJ, Aumont E, Hosseini SA, Fernandez Arias J, et al
    Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum.
    Neurology. 2026;106:e214606.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

56. GNANANANTHAN P, Houghton K, Chen M, Khagram P, et al
    Evaluation of the impact of novel digital PET/computed tomography reconstructions in Herder score calculations for the assessment of solitary pulmonary nodules on 2-[18F]fluoro-2-deoxy-D-glucose PET/computed tomography.
    Nucl Med Commun. 2026 Feb 2. doi: 10.1097/MNM.0000000000002115.
    PubMed         Abstract available
    
    
57. GRUNIG H, Krishnakumar S, Strobel K, Leike T, et al
    Is [18F] fluoro-d-glucose PET combined with computed tomography useful for staging of T1 lung cancer with pure solid morphology? How much and how far?
    Nucl Med Commun. 2026 Feb 2. doi: 10.1097/MNM.0000000000002119.
    PubMed         Abstract available
    
    
58. LU L, Meng D, Mo S, Sun Z, et al
    Evaluating the efficacy of the ResNet50 deep learning model utilizing thyroid scintigraphy images for predicting the outcomes of initial iodine-131 therapy in patients with Graves' disease.
    Nucl Med Commun. 2026;47:286-297.
    PubMed         Abstract available
    
    
59. JARVIS P, Dixon K, O'Shaughnessy E, Downs J, et al
    Sequential improvement in parathyroid adenoma localisation: optimising the 99m Tc-sestamibi washout study.
    Nucl Med Commun. 2026;47:280-285.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

60. FREESMEYER M, Kuhnel C, Voigt E, Schmidt TN, et al
    Radioiodine Therapy Unit as a "No-Care" Ward - A First Experience Report.
    Nuklearmedizin. 2026;65:22-29.
    PubMed         Abstract available
    
    

    
    PLoS One

61. MASE T, Toyomasu Y, Ishinaga H, Nanpei Y, et al
    Prognostic role of interim F-18 fluorodeoxyglucose positron emission tomography-computed tomography during chemoradiation therapy in patients with hypopharyngeal squamous cell carcinoma.
    PLoS One. 2026;21:e0341189.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. CIAMPA CJ, Morin TM, Parent JH, Adornato A, et al
    Dopaminergic mechanisms supporting hippocampal postencoding dynamics in humans.
    Proc Natl Acad Sci U S A. 2026;123:e2526799123.
    PubMed         Abstract available
    
    
63. TENDLER S, De Gregorio R, Balderes P, Michel AL, et al
    Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.
    Proc Natl Acad Sci U S A. 2026;123:e2505785123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum